Russian President Vladimir Putin warned Friday (Sept. AI development "raises colossal opportunities and threats that are difficult to predict now," Putin said in a lecture to students, warning that "it would be strongly undesirable if someone wins a monopolist position." Future wars will be fought by autonomous drones, Putin suggested, and "when one party's drones are destroyed by drones of another, it will have no other choice but to surrender." U.N. urged to address lethal autonomous weapons AI experts worldwide are also concerned. On August 20, 116 founders of robotics and artificial intelligence companies from 26 countries, including Elon Musk and Google DeepMind's Mustafa Suleyman, signed an open letter asking the United Nations to "urgently address the challenge of lethal autonomous weapons (often called'killer robots') and ban their use internationally."
An Associated Press investigation finds that Russian cyber spies exploiting a national vulnerability in cybersecurity are trying to break into the emails of scores of people working on military drone technology. An accused Russian hacker blamed for attacking LinkedIn, Dropbox and Formspring is finally facing American prosecutors after a lengthy extradition fight in the Czech Republic. Yevgeniy Aleksandrovich Nikulin is due to appear in U.S. federal court in California on Thursday for a detention hearing. It's unclear whether Nikulin has any connection to the Russian troll farm the Internet Research Agency, which is widely blamed by American authorities for interfering in the 2016 presidential election. But only two days after Nikulin's arrest, American officials for the first time publicly warned that the Russian government was directing efforts to influence the election by hacking and releasing private information.
Two years after originally announcing it, Medtronic and IBM Watson have launched their joint platform the Sugar.IQ, a digital diabetes assistant. "It is designed for people who are currently using Guardian Connect; so made for people on multiple daily injections. It is a personal assistant a little bit like Alexa or Siri," Huzefa Neemuchwala, global head of digital health solutions and AI at Medtronic, said in a Facebook live informational session. "It is an intelligent assistant that keeps track of all of your information and has all of your information in one place. Then through Watson technology we use this information to power insights so we can better manage your diabetes so that you can spend more time in range."
IBM Watson Health has announced a joint initiative with the US Food and Drug Administration to study the use of blockchain technology to share health data to ultimately improve public health. At first, the two-year collaboration will focus on oncology data, pulling together and exchanging data from a variety of sources including that from clinical trials, genomic data, EMRs, and from miscellaneous Internet of Things data from wearables, apps and connected devices. IBM and the FDA will look at how the technology can facilitate information exchange across a spectrum of data types, including clinical trials and real world data. For example, patient-generated data from connected devices could provide clinicians with more insights into population health, potentially offering up research opportunities and ways to leverage large quantities of data into biomedical and healthcare industries. At the core of the collaboration is blockchain technology, which allows secure data sharing between organizations more freely and has been increasingly favored among industry leaders.
The first FDA-approved AI system for diagnosing eye diseases caused by diabetes is completely autonomous, and doesn't require a doctor to interpret the results. Several corporations including Google and DeepMind have been working on building algorithms for diabetic retinography, a leading cause of blindness amongst adults. The first biz to release a device approved by the US Food and Drug Administration (FDA) earlier this year in April, however, is less well-known. IDx LLC, an AI diagnostics company based in Iowa, developed the tool known as IDx-DR. The details about the system were published in a paper in Nature Digital Medicine on Tuesday.